Quest Diagnostics, Inc. (DGX) Misses Q2 EPS by 4c; Guides In-Line
Tweet Send to a Friend
Quest Diagnostics, Inc. (NYSE: DGX) reported Q2 EPS of $1.06, $0.04 worse than the analyst estimate of $1.10. Revenue for ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
